| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.25 | 0.2 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |